Cargando…

Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection

Recent studies have demonstrated a potential link between circulating cell-free mitochondrial DNA (mtDNA) content and cancers. However, there is no study evaluating the association between circulating mtDNA as a non-invasive marker of hepatocellular carcinoma (HCC) risk. We conducted a nested case-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ling, Hann, Hie-Won, Wan, Shaogui, Hann, Richard S., Wang, Chun, Lai, Yinzhi, Ye, Xishan, Evans, Alison, Myers, Ronald E., Ye, Zhong, Li, Bingshan, Xing, Jinliang, Yang, Hushan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827061/ https://www.ncbi.nlm.nih.gov/pubmed/27063412 http://dx.doi.org/10.1038/srep23992

Ejemplares similares

Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients
por: Hann, Hie-Won, et al.
Publicado: (2012)

Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies – results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers
por: Wan, Shaogui, et al.
Publicado: (2013)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Genetic Polymorphism in a VEGF-Independent Angiogenesis Gene ANGPT1 and Overall Survival of Colorectal Cancer Patients after Surgical Resection
por: Dai, Jingyao, et al.
Publicado: (2012)

A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation
por: Hann, Hie-Won, et al.
Publicado: (2014)

Ferritin level prospectively predicts hepatocarcinogenesis in patients with chronic hepatitis B virus infection
por: Bian, Zhenyuan, et al.
Publicado: (2018)

Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma
por: Wan, Shaogui, et al.
Publicado: (2015)

Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
por: Bashir Hamidu, Rukaiya, et al.
Publicado: (2021)

Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
por: Lin, Selena Y., et al.
Publicado: (2023)

Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress
por: Noverati, Nicholas, et al.
Publicado: (2022)

Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes
por: Block, Peter D, et al.
Publicado: (2020)

Association of leukocyte mitochondrial DNA content with glioma risk: evidence from a Chinese case–control study
por: Zhang, Jie, et al.
Publicado: (2014)

The Role of Host in the Spectrum of Outcomes in Family Clusters of Hepatitis Infection: From Asymptomatic to Hepatocellular Carcinoma
por: Noverati, Nicholas, et al.
Publicado: (2023)

Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients
por: Chong, Weelic, et al.
Publicado: (2021)

Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)

Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma
por: Ye, Xinping, et al.
Publicado: (2018)

Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Wang, Chun, et al.
Publicado: (2021)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection
por: Wu, Chen, et al.
Publicado: (2020)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

Site-specific selection reveals selective constraints and functionality of tumor somatic mtDNA mutations
por: Li, Deyang, et al.
Publicado: (2017)

Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism
por: Abu-Khalaf, Maysa, et al.
Publicado: (2022)

Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes
por: Zhong, Xue, et al.
Publicado: (2015)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
por: Wei, Yanyan, et al.
Publicado: (2018)

Circulating Cell-Free mtDNA Content as a Non-invasive Prognostic Biomarker in HCC Patients Receiving TACE and Traditional Chinese Medicine
por: Zhou, Guanlin, et al.
Publicado: (2021)

Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma
por: Tao, Kaishan, et al.
Publicado: (2020)

Expanded circulating follicular dendritic cells facilitate immune responses in chronic HBV infection
por: Li, Xiaoyi, et al.
Publicado: (2020)

Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe
por: Chin'ombe, Nyasha, et al.
Publicado: (2009)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma
por: Zhang, Cunzhen, et al.
Publicado: (2022)

Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer
por: Luo, Rui, et al.
Publicado: (2021)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma
por: Zhang, Weilu, et al.
Publicado: (2020)

Highly differential count of circulating and tumor infiltrating immune cells in patients with non-HCV/non-HBV hepatocellular carcinoma
por: Schoenberg, Markus Bo, et al.
Publicado: (2021)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Long-read sequencing reveals the structural complexity of genomic integration of HBV DNA in hepatocellular carcinoma
por: Zhuo, Zhongling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_142vn9c8kvot68d4p7urv62628